SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Asthma/Allergy
An SI Board Since March 2001
Posts SubjectMarks Bans
86 25 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
11LONDON, May 23 (Reuters) - Novartis AG's Xolair allows patients with severe nigel bates-5/23/2001
10[ IL-4 receptor antagonist, asthma model ] Message 15786002scaram(o)uche-5/11/2001
9To:nigel bates who wrote (523) From: Miljenko Zuanic scaram(o)uche-4/27/2001
8intresting link in signalsmag signalsmag.com cheers Stefaandalroi-3/31/2001
7Interesting stuffpowerchip-3/23/2001
6Thursday March 22, 4:20 pm Eastern Time Press Release SOURCE: Immunex Corporatscaram(o)uche-3/22/2001
5Monday March 19, 11:12 am Eastern Time Press Release SOURCE: American Academy scaram(o)uche-3/21/2001
4Tuesday March 20, 8:01 am Eastern Time Press Release SOURCE: Lynx Therapeuticsscaram(o)uche-3/21/2001
3Magainin Pharmaceuticals is now Genaera Corporation (eom)scaram(o)uche-3/21/2001
2Tuesday March 20, 8:31 am Eastern Time Press Release SOURCE: Dynavax Technologscaram(o)uche-3/21/2001
1Monday March 19, 8:08 am Eastern Time Press Release IDEC Pharmaceuticals Annouscaram(o)uche-3/21/2001
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News